Indication
Non-Malignant Neoplasm
1 clinical trial
2 products
4 drugs
Clinical trial
Targeted Astatine-211-Labeled BC8-B10 Monoclonal Antibody as Reduced Intensity Conditioning for Nonmalignant DiseasesStatus: , Estimated PCD: 2028-01-09
Drug
fludarabineDrug
cyclophosphamideDrug
rapamycin